Scarce quality assurance documentation in major clinical trial registries for approved medicines used in post-marketing clinical trials.
- DOI
- 10.1186/s13063-019-3277-8
- Published
- 2019 Apr 11
- Container
- Trials
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13063-019-3277-8,
title = {Scarce quality assurance documentation in major clinical trial registries for approved medicines used in post-marketing clinical trials.},
author = {Doua YJ and Dominicus H and Mugwagwa J and Gombe SM and Nwokike J},
year = {2019},
journal = {Trials},
doi = {10.1186/s13063-019-3277-8},
url = {https://doi.org/10.1186/s13063-019-3277-8}
}RIS
TY - JOUR TI - Scarce quality assurance documentation in major clinical trial registries for approved medicines used in post-marketing clinical trials. AU - Doua YJ AU - Dominicus H AU - Mugwagwa J AU - Gombe SM AU - Nwokike J PY - 2019 JO - Trials DO - 10.1186/s13063-019-3277-8 UR - https://doi.org/10.1186/s13063-019-3277-8 ER -
APA
YJ, D., H, D., J, M., SM, G., & J, N. (2019). Scarce quality assurance documentation in major clinical trial registries for approved medicines used in post-marketing clinical trials.. Trials. https://doi.org/10.1186/s13063-019-3277-8
Source records
- pubmed · retrieved 2026-09-25T12:36:35.708Z